← Browse by Condition
Medical Condition
cardiac valve disease
Total Trials
2
Recruiting Now
2
Trial Phases
Various
ClinicalMetric tracks all active clinical trials for cardiac valve disease sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Top Sponsors
1 trial
1 trial
Recruiting Clinical Trials
NCT05506293
Recruiting
European Multicentre Registry of Percutaneous Paravalvular Leak Closure
Enrollment
400 pts
Location
Belgium, Czechia, Fr...
Sponsor
Centre Chirurgical Marie Lanne...
NCT06066970
Recruiting
Cardiac Biomarkers for the Quantification of Myocardial Damage After Cardiac Surgery
Enrollment
100 pts
Location
Germany
Sponsor
Jena University Hospital
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology